Claudin as a target for drug development

Current Medicinal Chemistry

Volumn 18, Issue 12, 2011, Pages 1861-1865

  Takahashi, A ^a   Kondoh, M ^a   Suzuki, H ^a   Yagi, K ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Cancer; Claudin; Infection; Inflammation; Tight junction

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL TOXIN; CANNABINOID; CLAUDIN; CLAUDIN 1; CLAUDIN 18 ANTIBODY; CLAUDIN 2; CLAUDIN 3; CLAUDIN 4; CLAUDIN 4 ANTIBODY; CLAUDIN 7; CLOSTRIDIUM PERFRINGENS ENTEROTOXIN; FORKHEAD TRANSCRIPTION FACTOR; INFLIXIMAB; MONOCLONAL ANTIBODY; OCCLUDIN; OMEGA 3 FATTY ACID; PROBIOTIC AGENT; PROTEIN SYNTHESIS INHIBITORY FACTOR; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FOXO4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER THERAPY; CLOSTRIDIUM PERFRINGENS; CROHN DISEASE; DRUG ABSORPTION; DRUG SYNTHESIS; DRUG TARGETING; ENDOTHELIUM CELL; ENTERITIS; EPITHELIUM CELL; FLAVIVIRUS INFECTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; NONHUMAN; OVARY CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; SMALL INTESTINE ABSORPTION; TIGHT JUNCTION; ULCERATIVE COLITIS; WEST NILE FLAVIVIRUS;

CLAUDINS; DRUG DELIVERY SYSTEMS; PHARMACOKINETICS; TIGHT JUNCTIONS;

EID: 79955704171     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986711795496809     Document Type: Article

References (76)

1. Anderson, J. Molecular structure of tight junctions and their role in epithelial transport. News Physiol. Sci., 2001, 16, 126-130. (Pubitemid 33570301)
2. Tsukita, S.; Furuse, M.; Itoh, M. Multifunctional strands in tight junctions. Nat. Rev. Mol. Cell Biol., 2001, 2, 285-293. (Pubitemid 33676971)
3. Furuse, M.; Fujita, K.; Hiiragi, T.; Fujimoto, K.; Tsukita, S. Claudin-1 and - 2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J. Cell Biol., 1998, 141, 1539-1550. (Pubitemid 28309169)
4. Furuse, M.; Hirase, T.; Itoh, M.; Nagafuchi, A.; Yonemura, S.; Tsukita, Sa.; Tsukita, Sh. Occludin: a novel integral membrane protein localizing at tight junctions. J. Cell Biol., 1993, 123, 1777-1788. (Pubitemid 24012933)
5. Furuse, M.; Tsukita, S. Claudins in occluding junctions of humans and flies. Trends Cell Biol., 2006, 16, 181-188.
6. Furuse, M.; Hata, M.; Furuse, K.; Yoshida, Y.; Haratake, A.; Sugitani, Y.; Noda, T.; Kubo, A.; Tsukita, S. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J. Cell Biol., 2002, 156, 1099-1111. (Pubitemid 34839858)
7. Nitta, T.; Hata, M.; Gotoh, S.; Seo, Y.; Sasaki, H.; Hashimoto, N.; Furuse, M.; Tsukita, S. Size-selective loosening of the blood-brain barrier in claudin- 5-deficient mice. J. Cell Biol., 2003, 161, 653-660. (Pubitemid 36578587)
8. Furuse, M.; Sasaki, H.; Tsukita, S. Manner of interaction of heterogeneous claudin species within and between tight junction strands. J. Cell Biol., 1999, 147, 891-903.
9. Ikenouchi, J.; Furuse, M.; Furuse, K.; Sasaki, H.; Tsukita, Sa.; Tsukida, Sh. Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells. J. Cell Biol., 2005, 171, 939-945. (Pubitemid 41815826)
10. Riazuddin, S.; Ahmed, Z.M.; Fanning, A.S.; Lagziel, A.; Kitajiri, S.; Ramzan, K.; Khan, S.N.; Chattaraj, P.; Friedman, P.L.; Anderson, J.M.; Belyantseva, I.A.; Forge, A.; Riazuddin, S.; Friedman, T.B. Tricellulin is a tight-junction protein necessary for hearing. Am. J. Hum. Genet., 2006, 79, 1040-1051. (Pubitemid 44853475)
11. Kondoh, M.; Yoshida, T.; Kakutani, H.; Yagi, K. Targeting tight junction proteins-significance for drug development. Drug Discov. Today, 2008, 13, 180-186.
12. Matsuhisa, K.; Kondoh, M.; Takahashi, A.; Yagi, K. Tight junction modulator and drug delivery. Expert Opin. Drug Deliv., 2009, 6, 509-515.
13. Kominsky, S.L. Claudins: emerging targets for cancer therapy. Expert Rev. Mol. Med., 2006, 8, 1-11. (Pubitemid 44184255)
14. Morin, P.J. Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res., 2005, 65, 9603-9606. (Pubitemid 41541431)
15. Swisshelm, K.; Macek, R.; Kubbies, M. Role of claudins in tumorigenesis. Adv. Drug Deliv. Rev., 2005, 57, 919-928. (Pubitemid 40488110)
16. Tsukita, Sa.; Yamazaki, Y.; Katsuno, T.; Tamura, A.; Tsukita, Sh. Tight junction-based epithelial microenvironment and cell proliferation. Oncogene, 2008, 27, 6930-6938.
17. Schulzke, D.; Ploeger, S.; Amasheh, M.; Fromm, A.; Zeissig, S.; Troeger, H.; Richter, J.; Bojarski, C.; Schumann, M.; Fromm, M. Epithelial tight junctions in intestinal inflammation. Ann. N.Y. Acad. Sci., 2009, 1165, 294-300.
18. Van Itallie, C.M.; Betts, L.; Smedley, J.G.3rd; McClane, B.A.; Anderson, J.M. Structure of the claudin-binding domain of Clostridium perfringens enterotoxin. J. Biol. Chem., 2008, 283, 268-274.
19. Argaw, A.T.; Gurfein, B.T.; Zhang, Y.; Zameer, A.; John, G.R. VEGFmediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc. Natl. Acad. Sci. USA, 2009, 106, 1977-1982.
20. Furuse, M. Knockout animals and natural mutations as experimental and diagnostic tool for studying tight junction functions in vivo. Biochim. Biophys. Acta., 2009, 1788, 813-819.
21. Sawada, N.; Murata, M.; Kikuchi, K.; Osanai, M.; Tobioka, H.; Kojima, T.; Chiba, H. Tight junctions and human diseases. Med. Electron. Microsc., 2003, 36, 147-156. (Pubitemid 37288275)
22. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Murray, T.; Thun, M.J. Cancer statistics, 2008. CA Cancer J. Clin., 2008, 58, 71-96.
23. Wodarz, A.; Nathke, I. Cell polarity in development and cancer. Nat. Cell Biol., 2007, 9, 1016-1024. (Pubitemid 47342312)
24. Honda, H.; Pazin, M.J.; Ji, H.; Wernyj, R.P.; Morin, P.J. Crucial roles of Sp1 and epigenetic modifications in the regulation of the CLDN4 promoter in ovarian cancer cells. J. Biol. Chem., 2006, 281, 21433-21444. (Pubitemid 44115482)
25. Li, J.; Sherman-Baust, C.A.; Tsai-Turton, M.; Bristow, R.E.; Roden, R.B.; Morin, P.J. Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer. BMC Cancer, 2009, 9, 244.
26. Suzuki, M.; Kato-Nakano, M.; Kawamoto, S.; Furuya, A.; Abe, Y.; Misaka, H.; Kimoto, N.; Nakamura, K.; Ohta, S.; Ando, H. Therapeutic antitumor efficacy of monoclonal antibody against Claudin-4 for pancreatic and ovarian cancers. Cancer Sci., 2009, 100, 1623-1630.
27. Yin, B.W.; Wong, G.Y.; Lloyd, K.O.; Oettgen, H.F.; Welt, S. Increased yields of IgG2a- and IgG3-secreting hybridomas after fusion of B cells from mice with autoimmune diseases. J. Immunol. Methods, 1991, 144, 165-173.
28. Pini, A.; Viti, F.; Santucci, A.; Carnemolla, B.; Zardi, L.; Neri, P.; Neri, D. Design and use of a phage display library. Human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a twodimensional gel. J. Biol. Chem., 1998, 273, 21769-21776. (Pubitemid 28405353)
29. Romani, C.; Comper, F.; Bandiera, E.; Ravaggi, A.; Bignotti, E.; Tassi, R.A.; Pecorelli, S.; Santin, A.D. Development and characterization of a human single- chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas. Am. J. Obstet. Gynecol., 2009, 201, 70. e71- 79.
30. Sahin, U.; Koslowski, M.; Dhaene, K.; Usener, D.; Brandenburg, G.; Seitz, G.; Huber, C.; Tureci, O. Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development. Clin. Cancer Res., 2008, 14, 7624-7634.
31. Hanna, P.C.; Wieckowski, E.U.; Mietzner, T.A.; McClane, B.A. Mapping of functional regions of Clostridium perfringens type A enterotoxin. Infect. Immun., 1992, 60, 2110-2114.
32. Fujita, K.; Katahira, J.; Horiguchi, Y.; Sonoda, N.; Furuse, M.; Tsukita, S. Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein. FEBS Lett., 2000, 476, 258-261. (Pubitemid 30410828)
33. Saeki, R.; Kondoh, M.; Kakutani, H.; Tsunoda, S.; Mochizuki, Y.; Hamakubo, T.; Tsutsumi, Y.; Horiguchi, Y.; Yagi, K. A novel tumor-targeted therapy using a claudin-4-targeting molecule. Mol. Pharmacol., 2009, 76, 918-926.
34. Yuan, X.; Lin, X.; Manorek, G.; Kanatani, I.; Cheung, L.H.; Rosenblum, M.G.; Howell, S.B. Recombinant CPE fused to tumor necrosis factor targets human ovarian cancer cells expressing the claudin-3 and claudin-4 receptors. Mol. Cancer Ther., 2009, 8, 1906-1915.
35. Huang, Y.H.; Bao, Y.; Peng, W.; Goldberg, M.; Love, K.; Bumcrot, D.A.; Cole, G.; Langer, R.; Anderson, D.G.; Swicki, J.A. Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis. Proc. Natl. Acad. Sci. USA, 2009, 106, 3426-3430.
36. Hayes, E.B.; Gubler, D.J. West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States. Annu. Rev. Med., 2006, 57, 181-194. (Pubitemid 43261986)
37. Samuel, M.A.; Diamond, M.S. Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J. Virol., 2006, 80, 9349-9360. (Pubitemid 44435614)
38. Klee, A.L.; Maidin, B.; Edwin, B.; Poshni, I.; Mostashari, F.; Fine, A.; Layton, M.; Nash, D. Long-term prognosis for clinical West Nile virus infection. Emerg. Infect. Dis., 2004, 10, 1405-1411. (Pubitemid 39014153)
39. Medigeshi, G.R.; Hirsch, A.J.; Brien, J.D.; Uhrlaub, J.L.; Mason, P.W.; Wiley, C.; Nikolich-Zugich, J.; Nelson, J.A. West nile virus capsid degradation of claudin proteins disrupts epithelial barrier function. J. Virol., 2009, 83, 6125-6134.
40. McArthur, J.C. HIV dementia: an evolving disease. J. Neuroimmunol., 2004, 157, 3-10. (Pubitemid 39576633)
41. Banks, W.A.; Ercal, N.; Price, T.O. The blood-brain barrier in neuroAIDS. Curr. HIV Res., 2006, 4, 259-266. (Pubitemid 44027716)
42. Hawkins, B.T.; Davis, T.P. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev., 2005, 57, 173-185. (Pubitemid 41043883)
43. Lu, T.S.; Avraham, H.K.; Seng, S.; Tachado, S.D.; Koziel, H.; Makriyannis, A.; Avraham, S. Cannabinoids inhibit HIV-1 Gp120-mediated insults in brain microvascular endothelial cells. J. Immunol., 2008, 181, 6406-6416.
44. Chaudhuri, A.; Yang, B.; Gendelman, H.E.; Persidsky, Y.; Kanmogne, G.D. STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier. Blood, 2008, 111, 2062-2072. (Pubitemid 351451518)
45. Pacher, P.; Batkai, S.; Kunos, G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev., 2006, 58, 389-462. (Pubitemid 44394908)
46. Bovolenta, C.; Camorali, L.; Lorini, A.L.; Ghezzi, S.; Vicenzi, E.; Lazzarin, A.; Poli, G. Constitutive activation of STATs upon in vivo human immunodeficiency virus infection. Blood, 1999, 94, 4202-4209.
47. Poynard, T.; Yuen, M.F.; Ratziu, V.; Lai, C.L. Viral hepatitis C. Lancet, 2003, 362, 2095-2100. (Pubitemid 38035201)
48. Pileri, P.; Uematsu, Y.; Campagnoli, S.; Galli, G.; Falugi, F.; Petracca, R.; Weiner, A.J.; Houghton, M.; Rosa, D.; Grandi, G.; Abrignani, S. Binding of hepatitis C virus to CD81. Science, 1998, 282, 938-941. (Pubitemid 28507525)
49. Scarselli, E.; Ansuini, H.; Cerino, R.; Roccasecca, R.M.; Acali, S.; Filocamo, G.; Traboni, C.; Nicosia, A.; Cortese, R.; Vitelli, A. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. Embo. J., 2002, 21, 5017-5025.
50. Bartosch, B.; Dubuisson, J.; Cosset, F.L. Infectious hepatitis C virus pseudoparticles containing functional E1-E2 envelope protein complexes. J. Exp. Med., 2003, 197, 633-642. (Pubitemid 36314658)
51. Evans, M.J.; von Hahn, T.; Tscherne, D.M.; Syder, A.J.; Panis, M.; Wolk, B.; Hatziioannou, T.; McKeating, J.A.; Bieniasz, P.D.; Rice, C.M. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature, 2007, 446, 801-805. (Pubitemid 46582027)
52. Ploss, A.; Evans, M.J.; Gaysinskaya, V.A.; Panis, M.; You, H.; de Jong, Y.P.; Rice, C.M. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature, 2009, 457, 882-886.
53. Gitter, A.H.; Wullstein, F.; Fromm, M.; Schulzke, J.D. Epithelial barrier defects in ulcerative colitis: characterization and quantification by electrophysiological imaging. Gastroenterology, 2001, 121, 1320-1328. (Pubitemid 33140449)
54. Marin, M.L.; Greenstein, A.J.; Geller, S.A.; Gordon, R.E.; Aufses, A.H., Jr. A freeze fracture study of Crohn's disease of the terminal ileum: changes in epithelial tight junction organization. Am. J. Gastroenterol., 1983, 78, 537-547. (Pubitemid 13000935)
55. Schmitz, H.; Barmeyer, C.; Fromm, M.; Runkel, N.; Foss, H.D.; Bentzel, C.J.; Riecken, E.O.; Schulzke, J.D. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology, 1999, 116, 301-309. (Pubitemid 29055352)
56. Oshima, T.; Miwa, H.; Joh, T. Changes in the expression of claudins in active ulcerative colitis. J. Gastroenterol. Hepatol., 2008, 23 Suppl 2, S146- 150.
57. Alexandre, M.D.; Lu, Q.; Chen, Y.H. Overexpression of claudin-7 decreases the paracellular Cl- conductance and increases the paracellular Na+ conductance in LLC-PK1 cells. J. Cell Sci., 2005, 118, 2683-2693. (Pubitemid 40932893)
58. Van Itallie, C.; Rahner, C.; Anderson, J.M. Regulated expression of claudin- 4 decreases paracellular conductance through a selective decrease in sodium permeability. J. Clin. Invest., 2001, 107, 1319-1327. (Pubitemid 32494549)
59. Shorter, R.G.; Huizenga, K.A.; Spencer, R.J.; Guy, S.K. Inflammatory bowel disease. The role of lymphotoxin in the cytotoxicity of lymphocytes for colonic epithelial cells. Am. J. Dig. Dis., 1972, 17, 689-696.
60. Kosiewicz, M.M.; Nast, C.C.; Krishnan, A.; Rivera-Nieves, J.; Moskaluk, C.A.; Matsumoto, S.; Kozaiwa, K.; Cominelli, F. Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease. J. Clin. Invest., 2001, 107, 695-702. (Pubitemid 32225355)
61. Reuter, B.K.; Pizarro, T.T. Mechanisms of tight junction dysregulation in the SAMP1/YitFc model of Crohn's disease-like ileitis. Ann. N.Y. Acad. Sci., 2009, 1165, 301-307.
62. Vidrich, A.; Buzan, J.M.; Barnes, S.; Reuter, B.K.; Skaar, K.; Ilo, C.; Cominelli, F.; Pizarro, T.; Cohn, S.M. Altered epithelial cell lineage allocation and global expansion of the crypt epithelial stem cell population are associated with ileitis in SAMP1/YitFc mice. Am. J. Pathol., 2005, 166, 1055-1067. (Pubitemid 40524430)
63. Paik, J.H.; Kollipara, R.; Chu, G.; Ji, H.; Xiao, Y.; Ding, Z.; Miao, L.; Tothova, Z.; Horner, J.W.; Carrasco, D.R.; Jiang, S.; Gilliland, D.G.; Chin, L.; Wong, W.H.; Castrillon, D.H.; DePinho, R.A. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell, 2007, 128, 309-323. (Pubitemid 46123514)
64. Tothova, Z.; Kollipara, R.; Huntly, B.J.; Lee, B.H.; Castrillon, D.H.; Cullen, D.E.; McDowell, E.P.; Lazo-Kallanian, S.; Williams, I.R.; Sears, C.; Armstrong, S.A.; Passegue, E.; DePinho, R.A.; Gilliland, D.G. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell, 2007, 128, 325-339. (Pubitemid 46137992)
65. Zhou, W.; Cao, Q.; Peng, Y.; Zhang, Q.J.; Castrillon, D.H.; DePinho, R.A.; Liu, Z.P. FoxO4 inhibits NF-kappaB and protects mice against colonic injury and inflammation. Gastroenterology, 2009, 137, 1403-1414.
66. Gitter, A.H.; Bendfeldt, K.; Schulzke, J.D.; Fromm, M. Leaks in the epithelial barrier caused by spontaneous and TNF-alpha-induced single-cell apoptosis. Faseb. J., 2000, 14, 1749-1753.
67. Mankertz, J.; Tavalali, S.; Schmitz, H.; Mankertz, A.; Riecken, E.O.; Fromm, M.; Schulzke, J.D. Expression from the human occludin promoter is affected by tumor necrosis factor alpha and interferon gamma. J. Cell. Sci., 2000, 113, 2085-2090. (Pubitemid 30386512)
68. Mankertz, J.; Amasheh, M.; Krug, S.M.; Fromm, A.; Amasheh, S.; Hillenbrand, B.; Tavalali, S.; Fromm, M.; Schulzke, J.D. TNFalpha up-regulates claudin-2 expression in epithelial HT-29/B6 cells via phosphatidylinositol-3- kinase signaling. Cell Tissue Res., 2009, 336, 67-77.
69. Fries, W.; Muja, C.; Crisafulli, C.; Cuzzocrea, S.; Mazzon, E. Dynamics of enterocyte tight junctions: effect of experimental colitis and two different anti-TNF strategies. Am. J. Physiol., 2008, 294, G938-947. (Pubitemid 351520063)
70. Aslan, A.; Triadafilopoulos, G. Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study. Am. J. Gastroenterol., 1992, 87, 432-437.
71. Hawthorne, A.B.; Daneshmend, T.K.; Hawkey, C.J.; Belluzzi, A.; Everitt, S.J.; Holmes, G.K.; Malkinson, C.; Shaheen, M.Z.; Willars, J.E. Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut, 1992, 33, 922-928.
72. Kitsukawa, Y.; Saito, H.; Suzuki, Y.; Kasanuki, J.; Tamura, Y.; Yoshida, S. Effect of ingestion of eicosapentaenoic acid ethyl ester on carrageenaninduced colitis in guinea pigs. Gastroenterology, 1992, 102, 1859-1866.
73. Li, Q.; Zhang, Q.; Zhang, M.; Wang, C.; Zhu, Z.; Li, N.; Li, J. Effect of n-3 polyunsaturated fatty acids on membrane microdomain localization of tight junction proteins in experimental colitis. Febs. J., 2008, 275, 411-420.
74. Fuller, R. Probiotics in man and animals. J. Appl. Bacteriol., 1989, 66, 365-378.
75. Mennigen, R.; Nolte, K.; Rijcken, E.; Utech, M.; Loeffler, B.; Senninger, N.; Bruewer, M. Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am. J. Physiol., 2009, 296, G1140-1149.
76. Takahashi, A.; Kondoh, M.; Masuyama, A.; Fujii, M.; Mizuguchi, H.; Horiguchi, Y.; Watanabe, Y. Role of C-terminal regions of the C-terminal fragment of Clostridium perfringens enterotoxin in its interaction with claudin-4. J. Control. Release, 2005, 108, 56-62. (Pubitemid 41476674)